Paclitaxel/Epigallocatechin gallate coloaded liposome: A synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells

Colloids and Surfaces B: Biointerfaces

Volumn 125, Issue , 2015, Pages 65-72

  Ramadass, Satiesh Kumar ^a   Anantharaman, Niranjana Vaighya ^b   Subramanian, Saravanan ^c   Sivasubramanian, Srinivasan ^d   Madhan, Balaraman ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY MADRAS   (India)

^c LOYOLA COLLEGE   (India)

^d Institute of Preventive Medicine   (India)

Author keywords

Breast cancer; Co delivery; Epigallocatechin gallate; Liposomes; Paclitaxel

Indexed keywords

CELL DEATH; CHEMOTHERAPY; DISEASES; ENZYME INHIBITION;

BREAST CANCER; BREAST CANCER CELLS; CO DELIVERIES; EPIGALLOCATECHIN GALLATE; MATRIX METALLOPROTEINASES; NOVEL STRATEGIES; PACLITAXEL; POTENTIAL TARGETS;

LIPOSOMES;

CASPASE 3; EPIGALLOCATECHIN GALLATE; GELATINASE A; GELATINASE B; LIPOSOME; PACLITAXEL; PLACEBO; ANTINEOPLASTIC AGENT; CATECHIN; MATRIX METALLOPROTEINASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL INVASION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPOSOMAL DELIVERY; METASTASIS INHIBITION; PARTICLE SIZE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; ANALOGS AND DERIVATIVES; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; FEMALE; GENE EXPRESSION; GENETICS; MAMMARY GLAND; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CATECHIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DRUG COMPOUNDING; DRUG SYNERGISM; FEMALE; GENE EXPRESSION; HUMANS; LIPOSOMES; MAMMARY GLANDS, HUMAN; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; PACLITAXEL;

EID: 84912124208     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2014.11.005     Document Type: Article

References (45)

1. Ferlay J., Soerjomataram I., Ervik M., et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] 2013, International Agency for Research on Cancer, Lyon, France, Available from: http://globocan.iarc.fr (accessed July 2014).
2. Rundhaug J.E. Clin. Cancer Res. 2003, 9:551.
3. Rundhaug J.E. Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med. 2005, 9:267.
4. Pellikainen J.M., Ropponen K.M., Kataja V.V., Kellokoski J.K., Eskelinen M.J., Kosma V.M. Clin. Cancer Res. 2004, 10:7621.
5. Schmalfeldt B., Prechtel D., Harting K., Spathe K., Rutke S., Konik E., Fridman R., Berger U., Schmitt M., Kuhn W., Lengyel E. Clin. Cancer Res. 2001, 7:2396.
6. Duffy M.J., Maguire T.M., Hill A., McDermott E., O'Higgins N. Breast Cancer Res. 2000, 2:252.
7. Kaelin W.G. Nat. Rev. Cancer 2005, 5:689.
8. Keith C.T., Borisy A.A., Stockwell B.R. Nat. Rev. Drug Discov. 2005, 4:71.
9. Lehar J., Krueger A.S., Avery W., Heilbut A.M., Johansen L.M., Price E.R., Rickles R.J., Short G.F., Staunton J.E., Jin X., Lee M.S., Zimmermann G.R., Borisy A.A. Nat. Biotechnol. 2009, 27:659.
10. Holmes F.A. Semin. Oncol. 1996, 23:46.
11. Davidson N.G. Semin. Oncol. 1996, 23:6.
12. Seidman A.D., Reichman B.S., Crown J.P., Yao T.J., Currie V., Hakes T.B., Hudis C.A., Gilewski T.A., Baselga J., Forsythe P., et al. J. Clin. Oncol. 1995, 13:1152.
13. Jordan M.A. Curr. Med. Chem. Anticancer Agents 2002, 2:1.
14. Khan N., Mukhtar H. Cancer Metastasis Rev. 2010, 29:435.
15. Mayerhofer K., Kucera E., Zeisler H., Speiser P., Reinthaller A., Sevelda P. Gynecol. Oncol. 1997, 64:109.
16. Luo T., Wang J., Yin Y., Hua H., Jing J., Sun X., Li M., Zhang Y., Jiang Y. Breast Cancer Res. 2010, 12:R8.
17. Wang H., Zhao Y., Wu Y., Hu Y.L., Nan K., Nie G., Chen H. Biomaterials 2011, 32:8281.
18. Taxol® (Paclitaxel) Injection, (accessed July 2014). http://www.rxlist.com/taxol-drug.htm.
19. Landis-Piwowar K., Chen D., Foldes R., Chan T.H., Dou Q.P. Expert. Opin. Ther. Pat. 2013, 23:189.
20. Huo C., Wan S.B., Lam W.H., Li L., Wang Z., Landis-Piwowar K.R., Chen D., Dou Q.P., Chan T.H. Inflammopharmacology 2008, 16:248.
21. Sanna V., Pintus G., Roggio A.M., Punzoni S., Posadino A.M., Arca A., Marceddu S., Bandiera P., Uzzau S., Sechi M. J. Med. Chem. 2011, 54:1321.
22. Hans M.L., Lowman A.M. Nanoparticles for Drug Delivery, Nanomaterials Handbook 2006, 657. CRC Press, (Chapter 23). Y. Gogotsi (Ed.).
23. Immordino M.L., Dosio F., Cattel L. Int. J. Nanomed. 2006, 1:297.
24. Tanaka S., Avigad G., Eikenberry E.F., Brodsky B. J. Biol. Chem. 1988, 263:17650.
25. Sommers C.L., Byers S.W., Thompson E.W., Torri J.A., Gelmann E.P. Breast Cancer Res. Treat. 1994, 31:325.
26. Kanda S., Kuzuya M., Ramos M.A., Koike T., Yoshino K., Ikeda S., Iguchi A. Arterioscler. Thromb. Vasc. Biol. 2000, 20:998.
27. Budai M., Szabo Z., Zimmer A., Szogyi M., Grof P. Int. J. Pharm. 2004, 279:67.
28. Kumar S. Cell Death Differ. 2007, 14:32.
29. Roy A.M., Baliga M.S., Katiyar S.K. Mol. Cancer. Ther 2005, 4:81.
30. Vayalil P.K., Katiyar S.K. Prostate 2004, 59:33.
31. Khan N., Afaq F., Saleem M., Ahmad N., Mukhtar H. Cancer Res. 2006, 66:2500.
32. Garbisa S., Sartor L., Biggin S., Salvato B., Benelli R., Albini A. Cancer 2001, 91:822.
33. Tutton M.G., George M.L., Eccles S.A., Burton S., Swift R.I., Abulafi A.M. Int. J. Cancer 2003, 107:541.
34. La Rocca G., Pucci-Minafra I., Marrazzo A., Taormina P., Minafra S. Br. J. Cancer 2004, 90:1414.
35. Klein G., Vellenga E., Fraaije M.W., Kamps W.A., de Bont E.S. Crit. Rev. Oncol. Hematol. 2004, 50:87.
36. Coussens L.M., Fingleton B., Matrisian L.M. Science 2002, 295:2387.
37. Hastak K., Gupta S., Ahmad N., Agarwal M.K., Agarwal M.L., Mukhtar H. Oncogene 2003, 22:4851.
38. Isemura M., Saeki K., Minami T., Hayakawa S., Kimura T., Shoji Y., Sazuka M. Ann. N.Y. Acad. Sci. 1999, 878:629.
39. Maeda-Yamamoto M., Kawahara H., Tahara N., Tsuji K., Hara Y., Isemura M. J. Agric. Food Chem. 1999, 47:2350.
40. Demeule M., Brossard M., Page M., Gingras D., Beliveau R. Biochim. Biophys. Acta 2000, 1478:51.
41. Garbisa S., Biggin S., Cavallarin N., Sartor L., Benelli R., Albini A. Nat. Med. 1999, 5:1216.
42. Makimura M., Hirasawa M., Kobayashi K., Indo J., Sakanaka S., Taguchi T., Otake S. J. Periodontol. 1993, 64:630.
43. Maeda-Yamamoto M., Suzuki N., Sawai Y., Miyase T., Sano M., Hashimoto-Ohta A., Isemura M. J. Agric. Food Chem. 2003, 51:1858.
44. Chambers A.F., Groom A.C., MacDonald I.C. Nat. Rev. Cancer 2002, 2:563.
45. Jung Y.D., Ellis L.M. Int. J. Exp. Pathol. 2001, 82:309.